Discussion on the biologic therapy of inflammatory bowel disease

被引:1
|
作者
Merger, M [1 ]
Herfarth, H
Scholmerich, J
Andus, T
Färber, L
机构
[1] Klinikum Univ Regensburg, Klin & Poliklin Innere Med 1, Regensburg, Germany
[2] Novartis, Nurnberg, Germany
关键词
D O I
10.1016/S0016-5085(03)00578-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2005 / 2006
页数:2
相关论文
共 50 条
  • [21] Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease
    Hindryckx, Pieter
    Novak, Gregor
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 633 - 641
  • [22] Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease
    Barrie, Arthur
    Regueiro, Miguel
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (11) : 1424 - 1429
  • [23] Monoclonal antibody therapy of inflammatory bowel disease - Discussion
    Elson, CO
    VanDeventer, JH
    Jewell, DP
    Mahida, YR
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 112 - 112
  • [24] Biologic therapies in inflammatory bowel disease
    Flamant, M.
    Bourreille, A.
    REVUE DE MEDECINE INTERNE, 2007, 28 (12): : 852 - 861
  • [25] Biologic therapies in inflammatory bowel disease
    Cohen, Lawrence B.
    Nanau, Radu M.
    Delzor, Faustine
    Neuman, Manuela G.
    TRANSLATIONAL RESEARCH, 2014, 163 (06) : 533 - 556
  • [26] How to Avoid Treating Irritable Bowel Syndrome with Biologic Therapy for Inflammatory Bowel Disease
    Sandborn, William J.
    DIGESTIVE DISEASES, 2009, 27 : 80 - 84
  • [27] Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease
    Matthew D McCormack
    Natasha A Wahedna
    David Aldulaimi
    Peter Hawker
    World Journal of Clinical Cases, 2023, (12) : 2621 - 2630
  • [28] Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease
    McCormack, Matthew D.
    Wahedna, Natasha A.
    Aldulaimi, David
    Hawker, Peter
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (12)
  • [29] Biologic therapy for Inflammatory Bowel Disease in Poland in 2020: nationwide data
    Kucha, P.
    Zagorowicz, E.
    Walkiewicz, D.
    Perwieniec, J.
    Maluchnik, M.
    Wieszczy, P.
    Regula, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I578 - I579
  • [30] INFECTIOUS COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECIEVING BIOLOGIC THERAPY
    Ochoa, C. D.
    Rajaram, P.
    Tanukonda, S.
    Sadikot, R. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 679 - 680